Though the prognosis significance of the autophagy gene GABARAPL1 in NPC patients has not been studied yet, low expression of GABARAPL1 has been demonstrated to be associated with poor prognosis in hepatocellular carcinoma and lymph node-positive breast cancer (15, 16). This evidence concerns the gene GABARAPL1 and nasopharyngeal carcinoma.